Martin Jacko
Founder & Chief Executive Officer Aperture Therapeutics
Seminars
Wednesday 29th April 2026
What is the Direction of New Targets? Different Target Identification Strategies
1:45 pm
- Reviewing the state of play of target identification and validation, and business rationale to explore newly discovered targets
- Leveraging human genetic data to understand the efficacy of new drugs
- Discussing the optimal moment for a biotech to partner a novel target identified through an innovative platform and whether the current deal-making landscape is favouring first-in-class or best-in-class
